Black Diamond Therapeutics (BDTX) Interest & Investment Income (2019 - 2026)
Black Diamond Therapeutics (BDTX) posted Interest & Investment Income of $1.0 million for Q1 2026, down 13.6% on a QoQ basis from $1.2 million in Q4 2025, and up 71.93% year-over-year from $595000.0 in Q1 2025.
Black Diamond Therapeutics (BDTX) Interest & Investment Income (2019 - 2026) Analysis & Trends
Black Diamond Therapeutics' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- Quarterly Interest & Investment Income rose 71.93% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (up 109.77% YoY) and the FY2025 annual result came in at $4.1 million, up 86.11% from the prior year.
- Interest & Investment Income was $1.0 million for Q1 2026 at Black Diamond Therapeutics, down from $1.2 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.2 million in Q4 2025 and bottomed at $324000.0 in Q4 2023.
- A 5-year average of $660058.8 and a median of $565000.0 in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income slumped 64.76% — and 2025, when it soared 140.95%.
- Black Diamond Therapeutics' Interest & Investment Income stood at $677000.0 in 2022, then plunged by 52.14% to $324000.0 in 2023, then jumped by 74.38% to $565000.0 in 2024, then soared by 109.56% to $1.2 million in 2025, then slipped by 13.6% to $1.0 million in 2026.
- Business Quant data shows BDTX's Interest & Investment Income at $1.0 million in Q1 2026, $1.2 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 595,000.00 |
| Dec 31, 2024 | 565,000.00 |
| Sep 30, 2024 | 516,000.00 |
| Jun 30, 2024 | 464,000.00 |
| Mar 31, 2024 | 637,000.00 |
| Dec 31, 2023 | 324,000.00 |
| Sep 30, 2023 | 439,000.00 |
| Jun 30, 2023 | 539,000.00 |
| Mar 31, 2023 | 622,000.00 |
| Dec 31, 2022 | 677,000.00 |
| Sep 30, 2022 | 562,000.00 |
| Jun 30, 2022 | 386,000.00 |
| Mar 31, 2022 | 406,000.00 |
| Dec 31, 2021 | 588,000.00 |
| Sep 30, 2021 | 776,000.00 |
| Jun 30, 2021 | 948,000.00 |